FLT4 and ductal breast carcinoma in situ: With respect to our findings, it is conceivable that determination of VEGF-C, ETAR, KDR, and Flt-4 expression may facilitate discrimination of a more angiogenic subset within the group of non-high-grade DCIS without coexistent invasive carcinoma.